Bristol-Myers Squibb's has become the first company to bring a cardiac myosin inhibitor through to FDA approval, claiming a green light from the US regulator for mavacamten as a therapy for ...
Bristol-Myers Squibb has announced its new-look leadership after the Celgene takeover goes through, and it reveals a mixed bag of new hires, sideways moves, and departures. The headline news is that ...
Lithium batteries have taken over as the primary battery chemistry from applications ranging from consumer electronics to ...
Abstract: Information and recommendations on the design, configuration, and interoperability of battery management systems in stationary applications is included in this recommended practice. The ...
In a market dominated by the cool kids—EcoFlow with their fancy apps and Jackery with their orange branding budgets—VTOMAN is the quiet kid in the back of the class who can bench press a Buick. I ...
Bristol Myers Squibb (NYSE: BMY) and Chinese biotech partner Sichuan Biokin (SHE: 688506) have reported a key win in the clinic, as their experimental antibody-drug conjugate iza-bren (izalontamab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results